Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $231,982 - $981,297
-108,912 Reduced 79.88%
27,429 $67,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $856,221 - $2.13 Million
136,341 New
136,341 $1.09 Million
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $196,092 - $303,646
-7,516 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $248,478 - $427,885
7,516 New
7,516 $287,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Echo Street Capital Management LLC Portfolio

Follow Echo Street Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo Street Capital Management LLC with notifications on news.